159 related articles for article (PubMed ID: 416322)
1. Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
Schade DS; Eaton RP; George S; Conway M; Kaminsky N; Sivinski J
Metabolism; 1978 Apr; 27(4):461-8. PubMed ID: 416322
[TBL] [Abstract][Full Text] [Related]
2. Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability.
Schade DS; Eaton RP
Diabetes; 1975 Nov; 24(11):1020-6. PubMed ID: 1183732
[TBL] [Abstract][Full Text] [Related]
3. Role of glucagon and other hormones in development of diabetic ketoacidosis.
Alberti KG
Lancet; 1975 Jun; 1(7920):1307-11. PubMed ID: 49515
[TBL] [Abstract][Full Text] [Related]
4. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
Schade DS; Eaton RP; Peake GT
Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
[No Abstract] [Full Text] [Related]
5. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute insulin deficiency on glucose and ketone body turnover in man: evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis.
Miles JM; Rizza RA; Haymond MW; Gerich JE
Diabetes; 1980 Nov; 29(11):926-30. PubMed ID: 6775996
[No Abstract] [Full Text] [Related]
7. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
Schade DS; Eaton RP
Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
[TBL] [Abstract][Full Text] [Related]
8. The metabolic response to norepinephrine in normal versus diabetic man.
Schade DS; Eaton RP
Diabetologia; 1978 Dec; 15(6):433-9. PubMed ID: 720776
[TBL] [Abstract][Full Text] [Related]
9. The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
Calvert GD; Blight L; Franklin J; Oliver J; Wise P; Gallus AS
Eur J Clin Pharmacol; 1980 May; 17(5):355-62. PubMed ID: 6998709
[No Abstract] [Full Text] [Related]
10. Insulin receptors on monocytes from patients with ketosis-prone diabetes mellitus.
Pedersen O; Beck-Nielsen H; Heding L
Diabetes; 1978 Nov; 27(11):1098-104. PubMed ID: 102554
[No Abstract] [Full Text] [Related]
11. Dose response to insulin in man: differential effects on glucose and ketone body regulation.
Schade DS; Eaton RP
J Clin Endocrinol Metab; 1977 Jun; 44(6):1038-53. PubMed ID: 874043
[No Abstract] [Full Text] [Related]
12. Glucagon regulation of plasma ketone body concentration in human diabetes.
Schade DS; Eaton RP
J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
[TBL] [Abstract][Full Text] [Related]
13. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
Ferrari C; Testori GP; Bertazzoni A; Romussi M; Caldara R; Frezzati S
Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
[TBL] [Abstract][Full Text] [Related]
14. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
Schade DS; Eaton RP
Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.
Burge MR; Garcia N; Qualls CR; Schade DS
Metabolism; 2001 Feb; 50(2):171-7. PubMed ID: 11229425
[TBL] [Abstract][Full Text] [Related]
16. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
Schade DS; Eaton RP
Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.
Diem P; Robertson RP
Br J Clin Pharmacol; 1991 Nov; 32(5):563-7. PubMed ID: 1954071
[TBL] [Abstract][Full Text] [Related]
18. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
[TBL] [Abstract][Full Text] [Related]
19. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
Eaton RP; Schade DS
Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
[No Abstract] [Full Text] [Related]
20. Biochemical characterization of ketosis-resistant young diabetics of northern India. In vivo effects of i.v. glucose, s.c. epinephrine and i.v. glucagon and in vitro effects of anti-insulin serum on adipose tissue lipolysis.
Krishna Ram B; Sachdev G; Chopra A; Karmarkar MG
Acta Diabetol Lat; 1984; 21(2):141-51. PubMed ID: 6433609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
